A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
Clinical trial NCT06088199 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06088199
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-24
- Primary completion
- 2026-08-06
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.